Axogen Inc (FRA:LT3)
€ 6.25 -0.25 (-3.85%) Market Cap: 285.76 Mil Enterprise Value: 333.88 Mil PE Ratio: 0 PB Ratio: 3.19 GF Score: 63/100

AxoGen Inc at Barclays Global Healthcare Conference Transcript

Mar 12, 2019 / 08:20PM GMT
Release Date Price: €17.11 (+1.48%)
Unidentified Analyst

(technical difficulty)

breakout session that follows where you'll have the opportunity for some Q&A.

So without further ado, Karen, I'll invite you up. Thank you.

Karen Zaderej
AxoGen, Inc. - Chairman, President & CEO

Thank you, and good afternoon, everybody. There. Super. AxoGen focuses in the area of peripheral nerve repair. Peripheral nerves impact people in lots of ways: a mother who cuts herself in the kitchen and later can't feel her baby's temperature with her fingers; a teenager who falls through a glass coffee table and loses mobility in a hand; a worker who's in a workplace injury and ends up suffering chronic pain following that workplace injury; someone who has their wisdom teeth extracted and ends up losing sensation in that half of the mouth as a complication of the procedure; a man who has erectile dysfunction following a prostatectomy. All of these are examples of injuries to peripheral nerves, a very common procedure and a very common impact.

So think of nerves as the wires of the body. They

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot